PhD Candidate
University of California San Francisco
Vincent Chang, BS., is currently a PhD candidate at University of California San Francisco in the Pharmaceutical Sciences and Pharmacogenomics graduate program. He is researching pharmacometric methods, stratified medicine approaches to treating drug sensitive tuberculosis with short-course rifapentine and moxifloxacin based regimens, and adaptive trial designs for their use in tuberculosis regiment development. He received the Lewis Sheiner student award in pharmacometrics from the Populations Approach Group Europe conference, and has presented his tuberculosis research at the Union Lung Health and TB Science conferences.
.png)